Related Experiment Video
Updated: Feb 28, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Genetic Predisposition to MASLD: Potential for Therapeutic Management
Fani Karapanagiotidi1, Chrysoula Boutari1, Emmanouil Sinakos1
14th Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642 Thessaloniki, Greece.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a growing global health issue. Genetic factors significantly influence MASLD, guiding precision medicine approaches for targeted treatments.
Area of Science:
- Hepatology and Genetic Epidemiology
Background:
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most prevalent liver condition globally, with rising incidence.
- Pathogenesis involves complex metabolic, environmental, and genetic factors.
Purpose of the Study:
- To review genetic variants influencing MASLD pathogenesis.
- To explore how these variants impact emerging pharmacotherapies and precision medicine.
Main Methods:
- Review of genome-wide association studies identifying key genetic variants (PNPLA3, TM6SF2, MBOAT7, GCKR, HSD17B13).
- Analysis of research on variant mechanisms in MASLD.
- Examination of clinical trials for precision medicine therapies.
Main Results:
- Specific genetic variants significantly contribute to MASLD development.
- These variants may affect patient response to novel drug therapies.
- Precision medicine offers individualized treatment strategies for MASLD.
Conclusions:
- Understanding genetic variants is crucial for MASLD pathogenesis.
- Pharmacogenomic approaches hold promise for targeted MASLD treatments.
- Clinical trials are evaluating precision medicine for MASLD management.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Sex-linked Disorders
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
